Juan Gnecco
Vanderbilt University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Juan Gnecco.
Hypertension | 2016
Allison E. Norlander; Mohamed A. Saleh; Nikhil Kamat; Ko Br; Juan Gnecco; Linjue Zhu; Bethany L. Dale; Yoichiro Iwakura; Robert S. Hoover; Alicia A. McDonough; Meena S. Madhur
Angiotensin II–induced hypertension is associated with an increase in T-cell production of interleukin-17A (IL-17A). Recently, we reported that IL-17A−/− mice exhibit blunted hypertension, preserved natriuresis in response to a saline challenge, and decreased renal sodium hydrogen exchanger 3 expression after 2 weeks of angiotensin II infusion compared with wild-type mice. In the current study, we performed renal transporter profiling in mice deficient in IL-17A or the related isoform, IL-17F, after 4 weeks of Ang II infusion, the time when the blood pressure reduction in IL-17A−/− mice is most prominent. Deficiency of IL-17A abolished the activation of distal tubule transporters, specifically the sodium–chloride cotransporter and the epithelial sodium channel and protected mice from glomerular and tubular injury. In human proximal tubule (HK-2) cells, IL-17A increased sodium hydrogen exchanger 3 expression through a serum and glucocorticoid-regulated kinase 1–dependent pathway. In mouse distal convoluted tubule cells, IL-17A increased sodium–chloride cotransporter activity in a serum and glucocorticoid-regulated kinase 1/Nedd4-2–dependent pathway. In both cell types, acute treatment with IL-17A induced phosphorylation of serum and glucocorticoid-regulated kinase 1 at serine 78, and treatment with a serum and glucocorticoid-regulated kinase 1 inhibitor blocked the effects of IL-17A on sodium hydrogen exchanger 3 and sodium–chloride cotransporter. Interestingly, both HK-2 and mouse distal convoluted tubule 15 cells produce endogenous IL-17A. IL17F had little or no effect on blood pressure or renal sodium transporter abundance. These studies provide a mechanistic link by which IL-17A modulates renal sodium transport and suggest that IL-17A inhibition may improve renal function in hypertension and other autoimmune disorders.
ACS Applied Materials & Interfaces | 2016
Virginia Pensabene; Lino Costa; Alexander Terekhov; Juan Gnecco; John P. Wikswo; William H. Hofmeister
The basal lamina or basement membrane (BM) is a key physiological system that participates in physicochemical signaling between tissue types. Its formation and function are essential in tissue maintenance, growth, angiogenesis, disease progression, and immunology. In vitro models of the BM (e.g., Boyden and transwell chambers) are common in cell biology and lab-on-a-chip devices where cells require apical and basolateral polarization. Extravasation, intravasation, membrane transport of chemokines, cytokines, chemotaxis of cells, and other key functions are routinely studied in these models. The goal of the present study was to integrate a semipermeable ultrathin polymer membrane with precisely positioned pores of 2 μm diameter in a microfluidic device with apical and basolateral chambers. We selected poly(l-lactic acid) (PLLA), a transparent biocompatible polymer, to prepare the semipermeable ultrathin membranes. The pores were generated by pattern transfer using a three-step method coupling femtosecond laser machining, polymer replication, and spin coating. Each step of the fabrication process was characterized by scanning electron microscopy to investigate reliability of the process and fidelity of pattern transfer. In order to evaluate the compatibility of the fabrication method with organs-on-a-chip technology, porous PLLA membranes were embedded in polydimethylsiloxane (PDMS) microfluidic devices and used to grow human umbilical vein endothelial cells (HUVECS) on top of the membrane with perfusion through the basolateral chamber. Viability of cells, optical transparency of membranes and strong adhesion of PLLA to PDMS were observed, thus confirming the suitability of the prepared membranes for use in organs-on-a-chip devices.
Cardiovascular Research | 2018
Roxana Loperena; Justin P. Van Beusecum; Hana A. Itani; Noah Engel; Fanny Laroumanie; Liang Xiao; Fernando Elijovich; Cheryl L. Laffer; Juan Gnecco; Jonathan Noonan; Pasquale Maffia; Barbara Jasiewicz-Honkisz; Marta Czesnikiewicz-Guzik; Tomasz Mikolajczyk; Tomasz Sliwa; Sergey Dikalov; Cornelia M. Weyand; Tomasz J. Guzik; David G. Harrison
Abstract Aims Monocytes play an important role in hypertension. Circulating monocytes in humans exist as classical, intermediate, and non-classical forms. Monocyte differentiation can be influenced by the endothelium, which in turn is activated in hypertension by mechanical stretch. We sought to examine the role of increased endothelial stretch and hypertension on monocyte phenotype and function. Methods and results Human monocytes were cultured with confluent human aortic endothelial cells undergoing either 5% or 10% cyclical stretch. We also characterized circulating monocytes in normotensive and hypertensive humans. In addition, we quantified accumulation of activated monocytes and monocyte-derived cells in aortas and kidneys of mice with Angiotensin II-induced hypertension. Increased endothelial stretch enhanced monocyte conversion to CD14++CD16+ intermediate monocytes and monocytes bearing the CD209 marker and markedly stimulated monocyte mRNA expression of interleukin (IL)-6, IL-1β, IL-23, chemokine (C-C motif) ligand 4, and tumour necrosis factor α. STAT3 in monocytes was activated by increased endothelial stretch. Inhibition of STAT3, neutralization of IL-6 and scavenging of hydrogen peroxide prevented formation of intermediate monocytes in response to increased endothelial stretch. We also found evidence that nitric oxide (NO) inhibits formation of intermediate monocytes and STAT3 activation. In vivo studies demonstrated that humans with hypertension have increased intermediate and non-classical monocytes and that intermediate monocytes demonstrate evidence of STAT3 activation. Mice with experimental hypertension exhibit increased aortic and renal infiltration of monocytes, dendritic cells, and macrophages with activated STAT3. Conclusions These findings provide insight into how monocytes are activated by the vascular endothelium during hypertension. This is likely in part due to a loss of NO signalling and increased release of IL-6 and hydrogen peroxide by the dysfunctional endothelium and a parallel increase in STAT activation in adjacent monocytes. Interventions to enhance bioavailable NO, reduce IL-6 or hydrogen peroxide production or to inhibit STAT3 may have anti-inflammatory roles in hypertension and related conditions.
British Journal of Pharmacology | 2018
Matthew R. Alexander; Allison E. Norlander; Fernando Elijovich; Ravi V Atreya; Amadou Gaye; Juan Gnecco; Cheryl L. Laffer; Cristi L. Galindo; Meena S. Madhur
Monocytes play a critical role in hypertension. The purpose of our study was to use an unbiased approach to determine whether hypertensive individuals on conventional therapy exhibit an altered monocyte gene expression profile and to perform validation studies of selected genes to identify novel therapeutic targets for hypertension.
American Journal of Reproductive Immunology | 2018
Lisa M. Rogers; Anjali P. Anders; Ryan S. Doster; Elizabeth A. Gill; Juan Gnecco; Jacob M. Holley; Tara M. Randis; Adam J. Ratner; Jennifer A. Gaddy; Kevin G. Osteen; David M. Aronoff
Bacterial chorioamnionitis causes adverse pregnancy outcomes, yet host‐microbial interactions are not well characterized within gestational membranes. The decidua, the outermost region of the membranes, is a potential point of entry for bacteria ascending from the vagina to cause chorioamnionitis. We sought to determine whether paracrine communication between decidual stromal cells and macrophages shaped immune responses to microbial sensing.
Reproductive Toxicology | 2017
Kaylon L. Bruner-Tran; Juan Gnecco; Tianbing Ding; Dana R. Glore; Virginia Pensabene; Kevin G. Osteen
Annals of Biomedical Engineering | 2017
Juan Gnecco; Virginia Pensabene; David J. Li; Tianbing Ding; Elliot E. Hui; Kaylon L. Bruner-Tran; Kevin G. Osteen
Current Pharmaceutical Design | 2017
Juan Gnecco; Anjali P. Anders; David E. Cliffel; Virginia Pensabene; Lisa M. Rogers; Kevin G. Osteen; David M. Aronoff
Journal of The American Society of Hypertension | 2015
Allison E. Norlander; Nikhil Kamat; Ko Br; Annet Kirabo; Juan Gnecco; Mohamed A. Saleh; Robert S. Hoover; David G. Harrison; Alicia A. McDonough; Meena S. Madhur
Hypertension | 2015
Allison E. Norlander; Nikhil Kamat; Ko Br; Annet Kirabo; Juan Gnecco; Mohamed A. Saleh; Robert S. Hoover; Alicia A. McDonough; Meena S. Madhur